Skip to main content

Private sector adoption of endometriosis tests doubles by Q4 2026

Resolves: Major private healthcare networks (e.g., BUPA, Spire) report availability of at least one of the two tests in twice as many locations as in Q2 2026.

Make a pick
user-generated· adoption

Private sector adoption of endometriosis tests doubles by Q4 2026

Market overview

Private healthcare providers in the UK currently lag in offering advanced diagnostic tools. If NHS endorsement drives credibility, private clinics will likely expand offerings to match demand, doubling test availability by Q4 2026.

adoption prediction market

Implied probability (Yes)
65%
Closes
2026-12-31

About this prediction

Resolution criteria

Major private healthcare networks (e.g., BUPA, Spire) report availability of at least one of the two tests in twice as many locations as in Q2 2026.

Source: user-generated

More adoption markets

Browse all adoption markets →

No one's made a Conviction call on this yet. Be the first to call it →
Loading…